(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol
![(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol Structure](https://image.chemsrc.com/caspic/061/131563-73-0.png)
(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol structure
|
Common Name | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol | ||
|---|---|---|---|---|
| CAS Number | 131563-73-0 | Molecular Weight | 301.33700 | |
| Density | 1.54g/cm3 | Boiling Point | 537.2ºC at 760mmHg | |
| Molecular Formula | C17H19NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 278.7ºC | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
|
Impurities in a morphine sulfate drug product identified as 5-(hydroxymethyl)-2-furfural, 10-hydroxymorphine and 10-oxomorphine.
J. Pharm. Sci. 92(3) , 485-93, (2003) Stability testing of morphine sulfate formulated with nonpareil sugar seeds (consisting of sucrose and starch) and fumaric acid revealed the formation of the three impurities 5-(hydroxymethyl)-2-furfural, 10-hydroxymorphine and 10-oxomorphine. 5-(Hydroxymethy... |
|
|
Morphine impurity with opioid activity is identified as 10 alpha-hydroxymorphine.
Pharm. Res. 7(11) , 1205-7, (1990)
|
|
|
Separation of morphine and its oxidation products by capillary zone electrophoresis.
J. Pharm. Biomed. Anal. 20(1-2) , 179-83, (1999) Separation of morphine and its oxidation products (10-S-hydroxymorphine, pseudomorphine and morphine N-oxide) by capillary zone electrophoresis in Tris-borate buffer in the presence of cyclodextrins was studied. Pyridoxine was used as an internal standard. |